Safety Study of the VEGA UV-A System to Treat Keratoconus
Public ClinicalTrials.gov record NCT01190306. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Study identification
- NCT ID
- NCT01190306
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Topcon Medical Systems, Inc.
- Industry
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Interventions
- Riboflavin Drug
- The VEGA UV-A Illumination System Device
Drug · Device
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2010
- Primary completion
- Nov 30, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Jul 11, 2022
2010 – 2011
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barnet Dulaney Perkins Eye Center | Phoenix | Arizona | 85016 | — |
| Woolfson Eye Institute | Atlanta | Georgia | 30328 | — |
| Minnesota Eye Consultants | Bloomington | Minnesota | 55431 | — |
| Pamel Vision & Laser Group | New York | New York | 10021 | — |
| Mt. Sinai Hospital | New York | New York | 10029 | — |
| OSU Department of Ophthalmoloty | Columbus | Ohio | 43212 | — |
| Revision Advanced Laser Eye Center | Columbus | Ohio | 43240 | — |
| Dell Laser Consultants | Austin | Texas | 78746 | — |
| Slade & Baker Vision Center | Houston | Texas | 77027 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01190306, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2022 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01190306 live on ClinicalTrials.gov.